Safe and Effective Treatment of Chronic Pain

Chorda Pharma was founded to address the growing incidence of arthritis, diabetic neuropathy, sports injuries, and other ailments requiring long-term treatment to relieve pain. We are developing a pipeline of proprietary analgesics for managing chronic pain. Our medications are opioid-free, and offer safe and effective pain relief to millions of patients. Chorda's first drug is an over-the-counter (OTC) topical cream that will be available in 2023.

web development

Growing Need for Non-Addictive Pain Relief

Arthritis is the number one cause of disability in America, with more than 54 million people afflicted. Common prescription medications such as corticosteroids and over the counter (OTC) treatments, including non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are not considered safe for long-term treatment of pain. Finding safe alternatives to traditional OTC and prescription-based pain relievers, like opioids, is an industry priority. According to the U.S. Department of Health and Human Services, addiction to opioid pain relievers has contributed to a national public health emergency, with 10 million patients misusing prescription opioids in the past year and over 70,000 drug overdose deaths.


Chorda Pharma Selected for Commercialization Grant

The Virginia Innovation Partnership Corporation (VIPC) has notified Chorda Pharma that it will receive a grant from the Commonwealth Commercialization Fund (CCF) for the Commercialization of a Non-Opioid Topical Analgesic. The $75,000 award will be used to help fund the testing, pilot manufacturing, and marketing of Capsadyn™, which offers relief for patients suffering from chronic pain.

Download the full announcement.

Radio interview with CEO Victor Iannello on WFIR